ATRX Contributes to MeCP2-Mediated Pericentric Heterochromatin Organization during Neural Differentiation

Area of Science:

• Genetics
• Neuroscience
• Epigenetics

Background:

• Methyl-CpG binding protein 2 (MeCP2) and Alpha-thalassemia/mental retardation syndrome X-linked protein (ATRX) are crucial for genome architecture, particularly pericentric heterochromatin (PCH) organization.
• Mutations in MECP2 cause Rett syndrome (RTT), and mutations in ATRX cause ATR-X syndrome, both associated with severe neurodevelopmental disorders.
• Both MeCP2 and ATRX proteins are found at chromocenters, which are repressive PCH domains.

Purpose of the Study:

• To investigate the functional interplay between MeCP2 and ATRX in the organization of pericentric heterochromatin.
• To elucidate the molecular mechanisms underlying chromocenter formation and maintenance involving MeCP2 and ATRX.
• To identify potential shared molecular defects in Rett syndrome and ATR-X syndrome.

Main Methods:

• Utilized murine embryonic stem cell lines with abolished MeCP2 or ATRX expression.
• Employed immunostaining, chromatin immunoprecipitation, and western blot analyses.
• Applied 3D-DNA fluorescence in situ hybridization (FISH) to visualize chromocenter clustering during neural differentiation.

Main Results:

• MeCP2 and ATRX exhibit reciprocal dependence for their expression and localization to chromocenters.
• ATRX influences the accumulation and expression of heterochromatin protein 1 (HP1) family members at PCH.
• Both ATRX and HP1 targeting to chromocenters are dependent on an RNA component.
• ATRX contributes to MeCP2-mediated chromocenter clustering during neural differentiation.

Conclusions:

• MeCP2 and ATRX are key regulators of higher-order pericentric heterochromatin organization in neurons.
• The findings reveal a detailed functional interplay between MeCP2 and ATRX.
• Alterations in pericentric heterochromatin organization represent a potential common molecular defect in Rett syndrome and ATR-X syndrome.